Agilent Presents Early Career Professor Award to Dr. Gary Patti
News Jul 11, 2017
Agilent Technologies has named Dr. Garry J. Patti, as the recipient of the prestigious 2017 Agilent Early Career Professor Award.
Dr. Patti, Associate Professor, Department of Chemistry Arts and Science, Washington University in St. Louis, was selected for his contributions to the detection of metabolomics changes in whole organisms and their utility for drug discovery, early detection, characterization and surveillance of cancer as well as other diseases and conditions.
Using state-of-the-art mass spectrometers coupled with cutting-edge metabolomic technologies, Dr. Patti’s lab takes a systems-level approach to the study of comprehensive metabolism and identification of specific pathways that are altered in connection with particular phenotypes.
“Agilent is pleased to recognize and support the work of Dr. Patti, who is developing and implementing experimental approaches that advance metabolomics analysis from the lab bench to translational applications in human disease,” said Jack Wenstrand, Director, University Relations and External Research at Agilent.
"Metabolism is one of the most exciting areas in biochemical research. We are honored to have one of the world's best in metabolomics here in our department," said Dr. William Buhro, Chairman, Department of Chemistry; George E. Pake Professor in Arts & Science Washington University in St. Louis.
The annual Agilent Early Career Professor Award was established in 2008. Through this award, Agilent seeks to recognize the achievements of academic researchers in the initial stages of their careers and to support and develop strong collaborative relationships with them at the beginning of their professional lives. This award underscores Agilent's commitment to furthering research through the company's products and services, financial support, and collaborative engagement by Agilent scientists and engineers.
This article has been republished from materials provided by Agilent Technologies. Note: material may have been edited for length and content. For further information, please contact the cited source.
Uptake of Controlled Release Drug Delivery Technology Set to Increase?News
The increasing access to healthcare facilities and the bolstering need for drugs to be used orally has been driving the consumption of generic drugs among people across the world, which, in turn, is fueling the need for controlled release technology for drug delivery to suffice the availability of drugs in small dosages.READ MORE
New Automated Screening Method for Identifying Drug CandidatesNews
Scientists at DESY have developed a new method that enables automated and fast screening of promising drug candidates.READ MORE
Metabolomic Profiling Identifies Taurine as New MS TherapeuticNews
New research suggests that administering taurine, a molecule naturally produced by human cells, could boost the effectiveness of current multiple sclerosis (MS) therapies. The discovery also highlights the potential for a technique called “metabolomic profiling,” which can identify useful endogenous metabolites the body already makes in small quantities, such as taurine, for new applications in drug therapies.READ MORE